chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Headache, Pain, Pain in extremity, Pruritus
Clinical narrative: massive headache; body ache; got hives all over body but did not experience difficulty in breathing; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were unknown), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received vaccine at work and the following day the patient experienced massive headache and body ache on an unspecified date. It was also reported that the next day, the patient got hives all over body but did not experience difficulty in breathing. The patient already spoke to her doctor regarding the adverse events that she experienced. Outcome of the events were unknown.   Information on the lot/Batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Urticaria
Clinical narrative: massive headache; body ache; got hives all over body but did not experience difficulty in breathing; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were unknown), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received vaccine at work and the following day the patient experienced massive headache and body ache on an unspecified date. It was also reported that the next day, the patient got hives all over body but did not experience difficulty in breathing. The patient already spoke to her doctor regarding the adverse events that she experienced. Outcome of the events were unknown.   Information on the lot/Batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Pain, Urticaria
Clinical narrative: massive headache; body ache; got hives all over body but did not experience difficulty in breathing; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were unknown), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received vaccine at work and the following day the patient experienced massive headache and body ache on an unspecified date. It was also reported that the next day, the patient got hives all over body but did not experience difficulty in breathing. The patient already spoke to her doctor regarding the adverse events that she experienced. Outcome of the events were unknown.   Information on the lot/Batch number has been requested.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Facial paralysis, Paraesthesia, Paraesthesia oral, Rash, Rash erythematous
Clinical narrative: Allergic reaction to vaccine; tingling to upper lip and face; tingling to upper lip and face; red rash on bilateral forearms; Patient developed Bell's Palsy 2-3 days later; This is a spontaneous report from a contactable consumer. A 45-year-old non-pregnant female patient received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL1284), via an unspecified route of administration on 23Dec2020 at 14:30 at single dose in left arm for covid-19 immunization. Medical history included mitral valve prolapse from an unknown date, and allergies: Cephalosporins and nut (peanut derived). Concomitant medication included epinephrine (EPIPEN) 0.3MG/0.3ML, fluticasone propionate 50MCG/ACT nasal spray. On 23Dec2020 at 14:45, the patient experienced allergic reaction to vaccine, tingling to upper lip and face, red rash on bilateral forearms. Reactions resolved with no treatment. The patient developed Bell's Palsy 2-3 days later in Dec2020. Currently being treated with high dose steroids and acyclovir. All events required emergency room visit and physician office visit. All events were reported as non-serious by reporter. The outcome of event Bell's Palsy was not resolved, outcome of other events was resolved on an unspecified date. The patient was not diagnosed with COVID-19 prior to vaccination, and it was unknown if the patient has been tested for COVID-19 since the vaccination.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination complication
Clinical narrative: Allergic reaction to vaccine; tingling to upper lip and face; tingling to upper lip and face; red rash on bilateral forearms; Patient developed Bell's Palsy 2-3 days later; This is a spontaneous report from a contactable consumer. A 45-year-old non-pregnant female patient received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL1284), via an unspecified route of administration on 23Dec2020 at 14:30 at single dose in left arm for covid-19 immunization. Medical history included mitral valve prolapse from an unknown date, and allergies: Cephalosporins and nut (peanut derived). Concomitant medication included epinephrine (EPIPEN) 0.3MG/0.3ML, fluticasone propionate 50MCG/ACT nasal spray. On 23Dec2020 at 14:45, the patient experienced allergic reaction to vaccine, tingling to upper lip and face, red rash on bilateral forearms. Reactions resolved with no treatment. The patient developed Bell's Palsy 2-3 days later in Dec2020. Currently being treated with high dose steroids and acyclovir. All events required emergency room visit and physician office visit. All events were reported as non-serious by reporter. The outcome of event Bell's Palsy was not resolved, outcome of other events was resolved on an unspecified date. The patient was not diagnosed with COVID-19 prior to vaccination, and it was unknown if the patient has been tested for COVID-19 since the vaccination.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Facial paralysis, Hypersensitivity, Paraesthesia, Paraesthesia oral, Rash
Clinical narrative: Allergic reaction to vaccine; tingling to upper lip and face; tingling to upper lip and face; red rash on bilateral forearms; Patient developed Bell's Palsy 2-3 days later; This is a spontaneous report from a contactable consumer. A 45-year-old non-pregnant female patient received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL1284), via an unspecified route of administration on 23Dec2020 at 14:30 at single dose in left arm for covid-19 immunization. Medical history included mitral valve prolapse from an unknown date, and allergies: Cephalosporins and nut (peanut derived). Concomitant medication included epinephrine (EPIPEN) 0.3MG/0.3ML, fluticasone propionate 50MCG/ACT nasal spray. On 23Dec2020 at 14:45, the patient experienced allergic reaction to vaccine, tingling to upper lip and face, red rash on bilateral forearms. Reactions resolved with no treatment. The patient developed Bell's Palsy 2-3 days later in Dec2020. Currently being treated with high dose steroids and acyclovir. All events required emergency room visit and physician office visit. All events were reported as non-serious by reporter. The outcome of event Bell's Palsy was not resolved, outcome of other events was resolved on an unspecified date. The patient was not diagnosed with COVID-19 prior to vaccination, and it was unknown if the patient has been tested for COVID-19 since the vaccination.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash erythematous
Clinical narrative: Allergic reaction to vaccine; tingling to upper lip and face; tingling to upper lip and face; red rash on bilateral forearms; Patient developed Bell's Palsy 2-3 days later; This is a spontaneous report from a contactable consumer. A 45-year-old non-pregnant female patient received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL1284), via an unspecified route of administration on 23Dec2020 at 14:30 at single dose in left arm for covid-19 immunization. Medical history included mitral valve prolapse from an unknown date, and allergies: Cephalosporins and nut (peanut derived). Concomitant medication included epinephrine (EPIPEN) 0.3MG/0.3ML, fluticasone propionate 50MCG/ACT nasal spray. On 23Dec2020 at 14:45, the patient experienced allergic reaction to vaccine, tingling to upper lip and face, red rash on bilateral forearms. Reactions resolved with no treatment. The patient developed Bell's Palsy 2-3 days later in Dec2020. Currently being treated with high dose steroids and acyclovir. All events required emergency room visit and physician office visit. All events were reported as non-serious by reporter. The outcome of event Bell's Palsy was not resolved, outcome of other events was resolved on an unspecified date. The patient was not diagnosed with COVID-19 prior to vaccination, and it was unknown if the patient has been tested for COVID-19 since the vaccination.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Migraine, Rash, Vomiting
Clinical narrative: Rash over face, torso, and arms. Vomiting and diarrhea day 3, and migraines for the firsts week; Rash over face, torso, and arms. Vomiting and diarrhea day 3, and migraines for the firsts week; Rash over face, torso, and arms. Vomiting and diarrhea day 3, and migraines for the firsts week; Rash over face, torso, and arms. Vomiting and diarrhea day 3, and migraines for the firsts week; Rash over face, torso, and arms. Vomiting and diarrhea day 3, and migraines for the firsts week; This is a spontaneous report from a contactable healthcare professional, the patient.  A 39-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EH9899), intramuscular, in the left arm on 23Dec2020 at 10:30 AM (at the age of 39-year-old) as a single dose for COVID-19 immunization. The patient medical history was not reported. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication taken within two weeks of vaccination was not reported. The patient previously took prochlorperazine edisylate (COMPAZINE) and experienced drug hypersensitivity. On 23Dec2020 at 8 PM, the patient experienced rash over face, torso, and arms. Vomiting and diarrhea day 3, and migraines for the firsts week. The events were reported as non-serious. The patient did not receive any treatment for the rash over face, torso, and arms. Vomiting and diarrhea day 3, and migraines for the firsts week. The clinical outcome of the events rash over face, torso, and arms. Vomiting and diarrhea day 3, and migraines for the firsts week was recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash, Rash erythematous, Rash papular
Clinical narrative: red, raised rashes appeared on chest and abdomen/spread to waist, both sides of the body, and buttocks/more red, raised rashes continues to appear on upper back, groins, thighs, bilateral armpit; This is a spontaneous report from a contactable nurse reporting for herself. A 47-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot number: EL0142, unknown expiration), via an unspecified route of administration on left arm, on 30Dec2020 at 12:45, at single dose, for COVID-19 immunization.  Medical history included asthma, hypertension, shell fish allergy, and COVID.  Concomitant medications included atenolol; fluticasone propionate, salmeterol (WIXELA INHUB); tocopherol (VITAMIN E); colecalciferol (VITAMIN D); ascorbic acid, bioflavonoids nos, hesperidin, malpighia glabra, rosa canina, rutoside (VITAMIN C); and bifidobacterium bifidum, bifidobacterium lactis, bifidobacterium longum, lactobacillus acidophilus, lactobacillus rhamnosus (PROBIOTIC).  The patient previously took chloramphenicol, diclofenac, and ketorolac, all experienced allergies. On 06Jan2021 at 05:30 AM, 7th day after vaccine, the patient experienced red, raised rashes appeared on chest and abdomen/continues to spread to waist, both sides of the body, and buttocks. On the 8th day, more red, raised rashes continues to appear on upper back, groins, thighs, bilateral armpit. The patient did not receive other vaccine in four weeks.  The patient received benadryl, methylprednisolone, and hydoxyzin for the event.  The patient was diagnosed with COVID-19 prior to vaccination and has been tested for COVID-19 post vaccination (pending result). The patient underwent lab tests and procedures which included COVID test: unknown result on unspecified date; Nasal Swab: negative on 06Jan2021; and PCR: Pending result on 06Jan2021. The adverse event result in doctor or other healthcare professional office/clinic visit. The patient had not yet recovered from the event. The event was assessed as non-serious.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash erythematous, SARS-CoV-2 test
Clinical narrative: red, raised rashes appeared on chest and abdomen/spread to waist, both sides of the body, and buttocks/more red, raised rashes continues to appear on upper back, groins, thighs, bilateral armpit; This is a spontaneous report from a contactable nurse reporting for herself. A 47-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot number: EL0142, unknown expiration), via an unspecified route of administration on left arm, on 30Dec2020 at 12:45, at single dose, for COVID-19 immunization.  Medical history included asthma, hypertension, shell fish allergy, and COVID.  Concomitant medications included atenolol; fluticasone propionate, salmeterol (WIXELA INHUB); tocopherol (VITAMIN E); colecalciferol (VITAMIN D); ascorbic acid, bioflavonoids nos, hesperidin, malpighia glabra, rosa canina, rutoside (VITAMIN C); and bifidobacterium bifidum, bifidobacterium lactis, bifidobacterium longum, lactobacillus acidophilus, lactobacillus rhamnosus (PROBIOTIC).  The patient previously took chloramphenicol, diclofenac, and ketorolac, all experienced allergies. On 06Jan2021 at 05:30 AM, 7th day after vaccine, the patient experienced red, raised rashes appeared on chest and abdomen/continues to spread to waist, both sides of the body, and buttocks. On the 8th day, more red, raised rashes continues to appear on upper back, groins, thighs, bilateral armpit. The patient did not receive other vaccine in four weeks.  The patient received benadryl, methylprednisolone, and hydoxyzin for the event.  The patient was diagnosed with COVID-19 prior to vaccination and has been tested for COVID-19 post vaccination (pending result). The patient underwent lab tests and procedures which included COVID test: unknown result on unspecified date; Nasal Swab: negative on 06Jan2021; and PCR: Pending result on 06Jan2021. The adverse event result in doctor or other healthcare professional office/clinic visit. The patient had not yet recovered from the event. The event was assessed as non-serious.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Fatigue, Headache, Muscular weakness, Palpitations
Clinical narrative: headaches for rest of day; severe dizziness; chest palpitations; extreme muscle weakness; projectile vomiting- all x15 minutes; fever of 101.1; general fatigue; This is a spontaneous report from a contactable nurse (patient). A 35-year-old female patient (non-pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK4176), intramuscular on 06Jan2021 14:30 at single dose at left arm for covid-19 immunization. Medical history included anxiety, osteoarthritis from an unknown date and unknown if ongoing. No known allergies to medications, food, or other products. Concomitant medications in two weeks included escitalopram oxalate (LEXAPRO), paracetamol (TYLENOL), ibuprofen. Patient previously received first dose of bnt162b2 (Batch/lot number: EH9899) intramuscular on 16Dec2020 14:45 at single dose at right arm for covid-19 immunization. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient has not been tested for COVID-19. The patient experienced severe dizziness, chest palpitations, extreme muscle weakness, projectile vomiting- all x15 minutes, followed by fever of 101.1 after paracetamol, general fatigue, headaches for rest of day from 07Jan2021 08:30 am with outcome of recovering. Patient didn't receive treatment for events. The adverse events resulted in neither doctor or other healthcare professional office/clinic visit, nor emergency room/department or urgent care. The report is considered as non-serious.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pyrexia, Vomiting projectile
Clinical narrative: headaches for rest of day; severe dizziness; chest palpitations; extreme muscle weakness; projectile vomiting- all x15 minutes; fever of 101.1; general fatigue; This is a spontaneous report from a contactable nurse (patient). A 35-year-old female patient (non-pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK4176), intramuscular on 06Jan2021 14:30 at single dose at left arm for covid-19 immunization. Medical history included anxiety, osteoarthritis from an unknown date and unknown if ongoing. No known allergies to medications, food, or other products. Concomitant medications in two weeks included escitalopram oxalate (LEXAPRO), paracetamol (TYLENOL), ibuprofen. Patient previously received first dose of bnt162b2 (Batch/lot number: EH9899) intramuscular on 16Dec2020 14:45 at single dose at right arm for covid-19 immunization. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient has not been tested for COVID-19. The patient experienced severe dizziness, chest palpitations, extreme muscle weakness, projectile vomiting- all x15 minutes, followed by fever of 101.1 after paracetamol, general fatigue, headaches for rest of day from 07Jan2021 08:30 am with outcome of recovering. Patient didn't receive treatment for events. The adverse events resulted in neither doctor or other healthcare professional office/clinic visit, nor emergency room/department or urgent care. The report is considered as non-serious.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Body temperature, Dizziness, Fatigue, Headache, Muscular weakness
Clinical narrative: headaches for rest of day; severe dizziness; chest palpitations; extreme muscle weakness; projectile vomiting- all x15 minutes; fever of 101.1; general fatigue; This is a spontaneous report from a contactable nurse (patient). A 35-year-old female patient (non-pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK4176), intramuscular on 06Jan2021 14:30 at single dose at left arm for covid-19 immunization. Medical history included anxiety, osteoarthritis from an unknown date and unknown if ongoing. No known allergies to medications, food, or other products. Concomitant medications in two weeks included escitalopram oxalate (LEXAPRO), paracetamol (TYLENOL), ibuprofen. Patient previously received first dose of bnt162b2 (Batch/lot number: EH9899) intramuscular on 16Dec2020 14:45 at single dose at right arm for covid-19 immunization. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient has not been tested for COVID-19. The patient experienced severe dizziness, chest palpitations, extreme muscle weakness, projectile vomiting- all x15 minutes, followed by fever of 101.1 after paracetamol, general fatigue, headaches for rest of day from 07Jan2021 08:30 am with outcome of recovering. Patient didn't receive treatment for events. The adverse events resulted in neither doctor or other healthcare professional office/clinic visit, nor emergency room/department or urgent care. The report is considered as non-serious.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Palpitations, Pyrexia, Vomiting projectile
Clinical narrative: headaches for rest of day; severe dizziness; chest palpitations; extreme muscle weakness; projectile vomiting- all x15 minutes; fever of 101.1; general fatigue; This is a spontaneous report from a contactable nurse (patient). A 35-year-old female patient (non-pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK4176), intramuscular on 06Jan2021 14:30 at single dose at left arm for covid-19 immunization. Medical history included anxiety, osteoarthritis from an unknown date and unknown if ongoing. No known allergies to medications, food, or other products. Concomitant medications in two weeks included escitalopram oxalate (LEXAPRO), paracetamol (TYLENOL), ibuprofen. Patient previously received first dose of bnt162b2 (Batch/lot number: EH9899) intramuscular on 16Dec2020 14:45 at single dose at right arm for covid-19 immunization. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient has not been tested for COVID-19. The patient experienced severe dizziness, chest palpitations, extreme muscle weakness, projectile vomiting- all x15 minutes, followed by fever of 101.1 after paracetamol, general fatigue, headaches for rest of day from 07Jan2021 08:30 am with outcome of recovering. Patient didn't receive treatment for events. The adverse events resulted in neither doctor or other healthcare professional office/clinic visit, nor emergency room/department or urgent care. The report is considered as non-serious.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Immediate post-injection reaction, Injection site erythema, Injection site swelling, Nausea
Clinical narrative: sever body aches; head ache; nausea; Arm where vaccine was giving was swollen and red; Arm where vaccine was giving was swollen and red; Arm where vaccine was giving was swollen and red and warm to the touch; This is a spontaneous report from a contactable other healthcare professional (patient). A 38-year-old female patient (no pregnancy) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685), via an unspecified route of administration at site of right arm at 15:00 on 28Dec2020 at single dose for COVID-19 immunization. Medical history included eczema psoriasis, allergies: Augmentin, and birth control. Concomitant medication included ethinylestradiol, norgestimate (TRI-SPRINTEC) for birth control within 2 weeks of vaccination and levocetirizine dihydrochloride (XYZAL). At 06:00 on 29Dec2020, the patient experienced sever body aches, headache and nausea. Arm where vaccine was giving was swollen and red and warm to the touch, body aches lasted for 24 hours, arm issue didn't not go away for 5 days. Facility where the most recent COVID-19 vaccine was administered was hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No treatment received for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. This case was identified as non-serious by reporter. The outcome of event arm where vaccine was giving was swollen and red and warm to the touch was recovered in Jan2021; of rest events was recovered at 06:00 on 30Dec2020.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain
Clinical narrative: sever body aches; head ache; nausea; Arm where vaccine was giving was swollen and red; Arm where vaccine was giving was swollen and red; Arm where vaccine was giving was swollen and red and warm to the touch; This is a spontaneous report from a contactable other healthcare professional (patient). A 38-year-old female patient (no pregnancy) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685), via an unspecified route of administration at site of right arm at 15:00 on 28Dec2020 at single dose for COVID-19 immunization. Medical history included eczema psoriasis, allergies: Augmentin, and birth control. Concomitant medication included ethinylestradiol, norgestimate (TRI-SPRINTEC) for birth control within 2 weeks of vaccination and levocetirizine dihydrochloride (XYZAL). At 06:00 on 29Dec2020, the patient experienced sever body aches, headache and nausea. Arm where vaccine was giving was swollen and red and warm to the touch, body aches lasted for 24 hours, arm issue didn't not go away for 5 days. Facility where the most recent COVID-19 vaccine was administered was hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No treatment received for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. This case was identified as non-serious by reporter. The outcome of event arm where vaccine was giving was swollen and red and warm to the touch was recovered in Jan2021; of rest events was recovered at 06:00 on 30Dec2020.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Nausea, Pain, Vaccination site erythema, Vaccination site swelling
Clinical narrative: sever body aches; head ache; nausea; Arm where vaccine was giving was swollen and red; Arm where vaccine was giving was swollen and red; Arm where vaccine was giving was swollen and red and warm to the touch; This is a spontaneous report from a contactable other healthcare professional (patient). A 38-year-old female patient (no pregnancy) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685), via an unspecified route of administration at site of right arm at 15:00 on 28Dec2020 at single dose for COVID-19 immunization. Medical history included eczema psoriasis, allergies: Augmentin, and birth control. Concomitant medication included ethinylestradiol, norgestimate (TRI-SPRINTEC) for birth control within 2 weeks of vaccination and levocetirizine dihydrochloride (XYZAL). At 06:00 on 29Dec2020, the patient experienced sever body aches, headache and nausea. Arm where vaccine was giving was swollen and red and warm to the touch, body aches lasted for 24 hours, arm issue didn't not go away for 5 days. Facility where the most recent COVID-19 vaccine was administered was hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No treatment received for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. This case was identified as non-serious by reporter. The outcome of event arm where vaccine was giving was swollen and red and warm to the touch was recovered in Jan2021; of rest events was recovered at 06:00 on 30Dec2020.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site warmth
Clinical narrative: sever body aches; head ache; nausea; Arm where vaccine was giving was swollen and red; Arm where vaccine was giving was swollen and red; Arm where vaccine was giving was swollen and red and warm to the touch; This is a spontaneous report from a contactable other healthcare professional (patient). A 38-year-old female patient (no pregnancy) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685), via an unspecified route of administration at site of right arm at 15:00 on 28Dec2020 at single dose for COVID-19 immunization. Medical history included eczema psoriasis, allergies: Augmentin, and birth control. Concomitant medication included ethinylestradiol, norgestimate (TRI-SPRINTEC) for birth control within 2 weeks of vaccination and levocetirizine dihydrochloride (XYZAL). At 06:00 on 29Dec2020, the patient experienced sever body aches, headache and nausea. Arm where vaccine was giving was swollen and red and warm to the touch, body aches lasted for 24 hours, arm issue didn't not go away for 5 days. Facility where the most recent COVID-19 vaccine was administered was hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No treatment received for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. This case was identified as non-serious by reporter. The outcome of event arm where vaccine was giving was swollen and red and warm to the touch was recovered in Jan2021; of rest events was recovered at 06:00 on 30Dec2020.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Chills, Diarrhoea, Ear infection, Ear pain
Clinical narrative: Per patient report: On 1/1/2021 she started to have a fever, HA, ear pain, neck pain (back of neck), and muscle aches in upper back.  This continued through the weekend.   On Wednesday, 1/6/2021, she saw a provider for ear pain, chest pain (radiating to right arm).  She was not prescribed/given treatment regimen.  On Thursday, 1/7/2021, night, she started to have vomiting diarrhea, and chest pain.  On Friday, 1/8/2021, she went in to be seen for chest pain and r/o PE.  States she has a history of PE and had a CT performed, no clots found.   EE states does not have vomiting and diarrhea from 1/13/2021 for the first time since the start of this symptoms.  Continues to have GI issues: decreased appetite and upset stomach.  Also states she feels very fatigued.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Influenza virus test negative, Nausea, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: Per patient report: On 1/1/2021 she started to have a fever, HA, ear pain, neck pain (back of neck), and muscle aches in upper back.  This continued through the weekend.   On Wednesday, 1/6/2021, she saw a provider for ear pain, chest pain (radiating to right arm).  She was not prescribed/given treatment regimen.  On Thursday, 1/7/2021, night, she started to have vomiting diarrhea, and chest pain.  On Friday, 1/8/2021, she went in to be seen for chest pain and r/o PE.  States she has a history of PE and had a CT performed, no clots found.   EE states does not have vomiting and diarrhea from 1/13/2021 for the first time since the start of this symptoms.  Continues to have GI issues: decreased appetite and upset stomach.  Also states she feels very fatigued.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: Per patient report: On 1/1/2021 she started to have a fever, HA, ear pain, neck pain (back of neck), and muscle aches in upper back.  This continued through the weekend.   On Wednesday, 1/6/2021, she saw a provider for ear pain, chest pain (radiating to right arm).  She was not prescribed/given treatment regimen.  On Thursday, 1/7/2021, night, she started to have vomiting diarrhea, and chest pain.  On Friday, 1/8/2021, she went in to be seen for chest pain and r/o PE.  States she has a history of PE and had a CT performed, no clots found.   EE states does not have vomiting and diarrhea from 1/13/2021 for the first time since the start of this symptoms.  Continues to have GI issues: decreased appetite and upset stomach.  Also states she feels very fatigued.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Chest pain, Computerised tomogram, Decreased appetite, Diarrhoea
Clinical narrative: Per patient report: On 1/1/2021 she started to have a fever, HA, ear pain, neck pain (back of neck), and muscle aches in upper back.  This continued through the weekend.   On Wednesday, 1/6/2021, she saw a provider for ear pain, chest pain (radiating to right arm).  She was not prescribed/given treatment regimen.  On Thursday, 1/7/2021, night, she started to have vomiting diarrhea, and chest pain.  On Friday, 1/8/2021, she went in to be seen for chest pain and r/o PE.  States she has a history of PE and had a CT performed, no clots found.   EE states does not have vomiting and diarrhea from 1/13/2021 for the first time since the start of this symptoms.  Continues to have GI issues: decreased appetite and upset stomach.  Also states she feels very fatigued.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ear pain, Fatigue, Gastrointestinal disorder, Headache, Myalgia
Clinical narrative: Per patient report: On 1/1/2021 she started to have a fever, HA, ear pain, neck pain (back of neck), and muscle aches in upper back.  This continued through the weekend.   On Wednesday, 1/6/2021, she saw a provider for ear pain, chest pain (radiating to right arm).  She was not prescribed/given treatment regimen.  On Thursday, 1/7/2021, night, she started to have vomiting diarrhea, and chest pain.  On Friday, 1/8/2021, she went in to be seen for chest pain and r/o PE.  States she has a history of PE and had a CT performed, no clots found.   EE states does not have vomiting and diarrhea from 1/13/2021 for the first time since the start of this symptoms.  Continues to have GI issues: decreased appetite and upset stomach.  Also states she feels very fatigued.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neck pain, Pain, Pyrexia, SARS-CoV-2 test negative, Vomiting
Clinical narrative: Per patient report: On 1/1/2021 she started to have a fever, HA, ear pain, neck pain (back of neck), and muscle aches in upper back.  This continued through the weekend.   On Wednesday, 1/6/2021, she saw a provider for ear pain, chest pain (radiating to right arm).  She was not prescribed/given treatment regimen.  On Thursday, 1/7/2021, night, she started to have vomiting diarrhea, and chest pain.  On Friday, 1/8/2021, she went in to be seen for chest pain and r/o PE.  States she has a history of PE and had a CT performed, no clots found.   EE states does not have vomiting and diarrhea from 1/13/2021 for the first time since the start of this symptoms.  Continues to have GI issues: decreased appetite and upset stomach.  Also states she feels very fatigued.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fatigue, Pain, Pruritus
Clinical narrative: Itchy on her right arm and upper right torso area; Dizzy and lightheaded; This is a spontaneous report from a contactable nurse (patient). A 36-year-old-female patient (non-pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: ELO140), via an unspecified route of administration in right arm, on 06Jan2021 at 08:30, at a single dose, for COVID-19 immunization. The patient's medical history included allergies to gluten and penicillin (PCN). There were no concomitant medications. The patient previously took cefaclor (CECLOR) and experienced allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The most recent COVID-19 vaccine was administered in the patient's workplace clinic. The first dose was given at 08:30 on 06Jan2021. A few minutes after, the patient became dizzy and lightheaded for what seemed like a minute or two and then she was fine for the remainder of her 15-minute observation. Around 17:00 that day, the patient became itchy on her right arm and upper right torso area, no rash or swelling was noted. Itching subsided around 20:00 - almost 12 hours post-vaccine. The events were considered non-serious. No treatment was received for the adverse events. Since the vaccination, the patient has not been tested for COVID-19. The patient recovered from the events on 06Jan2021 ("Itchy on her right arm and upper right torso area" at 20:00).
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Pruritus
Clinical narrative: Itchy on her right arm and upper right torso area; Dizzy and lightheaded; This is a spontaneous report from a contactable nurse (patient). A 36-year-old-female patient (non-pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: ELO140), via an unspecified route of administration in right arm, on 06Jan2021 at 08:30, at a single dose, for COVID-19 immunization. The patient's medical history included allergies to gluten and penicillin (PCN). There were no concomitant medications. The patient previously took cefaclor (CECLOR) and experienced allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The most recent COVID-19 vaccine was administered in the patient's workplace clinic. The first dose was given at 08:30 on 06Jan2021. A few minutes after, the patient became dizzy and lightheaded for what seemed like a minute or two and then she was fine for the remainder of her 15-minute observation. Around 17:00 that day, the patient became itchy on her right arm and upper right torso area, no rash or swelling was noted. Itching subsided around 20:00 - almost 12 hours post-vaccine. The events were considered non-serious. No treatment was received for the adverse events. Since the vaccination, the patient has not been tested for COVID-19. The patient recovered from the events on 06Jan2021 ("Itchy on her right arm and upper right torso area" at 20:00).
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Alanine aminotransferase normal, Blood albumin decreased, Blood bilirubin increased, Blood glucose increased, Eosinophil percentage decreased
Clinical narrative: Chills starting at 2am, sweats, fever, weakness, extreme nausea, headache, backache, tingling fingers Came to Clinic for outpatient IV's around 1030am... of fluid (LR), Doxycycline, Zofran, Tylenol, Toradol, Fentanyl....went home around 4pm feeling better.  The headache finally went away Friday sometime (1/8/21)...  weakness is getting better
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Lymphocyte count decreased, Lymphocyte percentage decreased, Monocyte percentage
Clinical narrative: Chills starting at 2am, sweats, fever, weakness, extreme nausea, headache, backache, tingling fingers Came to Clinic for outpatient IV's around 1030am... of fluid (LR), Doxycycline, Zofran, Tylenol, Toradol, Fentanyl....went home around 4pm feeling better.  The headache finally went away Friday sometime (1/8/21)...  weakness is getting better
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Neutrophil percentage increased, Pain, Protein total decreased, Pyrexia
Clinical narrative: Chills starting at 2am, sweats, fever, weakness, extreme nausea, headache, backache, tingling fingers Came to Clinic for outpatient IV's around 1030am... of fluid (LR), Doxycycline, Zofran, Tylenol, Toradol, Fentanyl....went home around 4pm feeling better.  The headache finally went away Friday sometime (1/8/21)...  weakness is getting better
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Back pain, Chills, Headache, Hyperhidrosis
Clinical narrative: Chills starting at 2am, sweats, fever, weakness, extreme nausea, headache, backache, tingling fingers Came to Clinic for outpatient IV's around 1030am... of fluid (LR), Doxycycline, Zofran, Tylenol, Toradol, Fentanyl....went home around 4pm feeling better.  The headache finally went away Friday sometime (1/8/21)...  weakness is getting better
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Metabolic function test, Nausea, Paraesthesia, Pyrexia
Clinical narrative: Chills starting at 2am, sweats, fever, weakness, extreme nausea, headache, backache, tingling fingers Came to Clinic for outpatient IV's around 1030am... of fluid (LR), Doxycycline, Zofran, Tylenol, Toradol, Fentanyl....went home around 4pm feeling better.  The headache finally went away Friday sometime (1/8/21)...  weakness is getting better
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Headache, Injection site pain, Malaise
Clinical narrative: injection site pain; tiredness; headache; muscle pain; chills; nausea; feeling unwell; This is a spontaneous report from a contactable pharmacist (patient). This 32--year-old female pharmacist reported for herself received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number: EK9231/expiration date: unknown), via intramuscular route of administration, on 06Jan2021 at 09:30 AM (at the age of 32 years old) as a single dose in the left arm for COVID-19 immunization at hospital facility. Relevant medical history was not provided. The patient did not have any known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included bupropion hydrochloride (WELLBUTRIN XR) 300mg daily, levothyroxine 25mcg QAM and prenatal vitamin one-a-day. The patient previously received the first dose of BNT162B2 (lot number: EH9899/expiration date: unknown) on 16Dec2020 at 09:30 AM (at the age of 32 years old) as a single dose in the left arm for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 06Jan2021 at 09:00 PM, after the second dose, the patient experienced injection site pain, tiredness, headache, muscle pain, chills, nausea, feeling unwell. Treatment was received for the events injection site pain, tiredness, headache, muscle pain, chills, nausea, feeling unwell included Acetaminophen 1000mg Q6Hrs. The outcome of the events injection site pain, tiredness, headache, muscle pain, chills, nausea, feeling unwell was unknown. Since the vaccination, the patient had not been tested for COVID-19.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Nausea
Clinical narrative: injection site pain; tiredness; headache; muscle pain; chills; nausea; feeling unwell; This is a spontaneous report from a contactable pharmacist (patient). This 32--year-old female pharmacist reported for herself received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number: EK9231/expiration date: unknown), via intramuscular route of administration, on 06Jan2021 at 09:30 AM (at the age of 32 years old) as a single dose in the left arm for COVID-19 immunization at hospital facility. Relevant medical history was not provided. The patient did not have any known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included bupropion hydrochloride (WELLBUTRIN XR) 300mg daily, levothyroxine 25mcg QAM and prenatal vitamin one-a-day. The patient previously received the first dose of BNT162B2 (lot number: EH9899/expiration date: unknown) on 16Dec2020 at 09:30 AM (at the age of 32 years old) as a single dose in the left arm for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 06Jan2021 at 09:00 PM, after the second dose, the patient experienced injection site pain, tiredness, headache, muscle pain, chills, nausea, feeling unwell. Treatment was received for the events injection site pain, tiredness, headache, muscle pain, chills, nausea, feeling unwell included Acetaminophen 1000mg Q6Hrs. The outcome of the events injection site pain, tiredness, headache, muscle pain, chills, nausea, feeling unwell was unknown. Since the vaccination, the patient had not been tested for COVID-19.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Headache, Malaise, Myalgia
Clinical narrative: injection site pain; tiredness; headache; muscle pain; chills; nausea; feeling unwell; This is a spontaneous report from a contactable pharmacist (patient). This 32--year-old female pharmacist reported for herself received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number: EK9231/expiration date: unknown), via intramuscular route of administration, on 06Jan2021 at 09:30 AM (at the age of 32 years old) as a single dose in the left arm for COVID-19 immunization at hospital facility. Relevant medical history was not provided. The patient did not have any known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included bupropion hydrochloride (WELLBUTRIN XR) 300mg daily, levothyroxine 25mcg QAM and prenatal vitamin one-a-day. The patient previously received the first dose of BNT162B2 (lot number: EH9899/expiration date: unknown) on 16Dec2020 at 09:30 AM (at the age of 32 years old) as a single dose in the left arm for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 06Jan2021 at 09:00 PM, after the second dose, the patient experienced injection site pain, tiredness, headache, muscle pain, chills, nausea, feeling unwell. Treatment was received for the events injection site pain, tiredness, headache, muscle pain, chills, nausea, feeling unwell included Acetaminophen 1000mg Q6Hrs. The outcome of the events injection site pain, tiredness, headache, muscle pain, chills, nausea, feeling unwell was unknown. Since the vaccination, the patient had not been tested for COVID-19.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Vaccination site pain
Clinical narrative: injection site pain; tiredness; headache; muscle pain; chills; nausea; feeling unwell; This is a spontaneous report from a contactable pharmacist (patient). This 32--year-old female pharmacist reported for herself received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number: EK9231/expiration date: unknown), via intramuscular route of administration, on 06Jan2021 at 09:30 AM (at the age of 32 years old) as a single dose in the left arm for COVID-19 immunization at hospital facility. Relevant medical history was not provided. The patient did not have any known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included bupropion hydrochloride (WELLBUTRIN XR) 300mg daily, levothyroxine 25mcg QAM and prenatal vitamin one-a-day. The patient previously received the first dose of BNT162B2 (lot number: EH9899/expiration date: unknown) on 16Dec2020 at 09:30 AM (at the age of 32 years old) as a single dose in the left arm for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 06Jan2021 at 09:00 PM, after the second dose, the patient experienced injection site pain, tiredness, headache, muscle pain, chills, nausea, feeling unwell. Treatment was received for the events injection site pain, tiredness, headache, muscle pain, chills, nausea, feeling unwell included Acetaminophen 1000mg Q6Hrs. The outcome of the events injection site pain, tiredness, headache, muscle pain, chills, nausea, feeling unwell was unknown. Since the vaccination, the patient had not been tested for COVID-19.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swollen tongue
Clinical narrative: immediate swelling at injection site, anaphylactic reaction with oxygen desaturation, throat swelling and tachycardia.    supplemenmental oxygen, IV fluids, epinepherine IM, benadryl given at vaccine site, transported to Emergency Room via ambulance.  I was stable at the time of transport.  IV solumedrol and pepcid given at hospital. EKG and bloodwork done.  I had low potassium and was provided supplement. discharged and prescribed Prednasone, Pepcid, Zyrtic and potassium
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction, Blood potassium decreased, Blood test, Electrocardiogram, Immediate post-injection reaction
Clinical narrative: immediate swelling at injection site, anaphylactic reaction with oxygen desaturation, throat swelling and tachycardia.    supplemenmental oxygen, IV fluids, epinepherine IM, benadryl given at vaccine site, transported to Emergency Room via ambulance.  I was stable at the time of transport.  IV solumedrol and pepcid given at hospital. EKG and bloodwork done.  I had low potassium and was provided supplement. discharged and prescribed Prednasone, Pepcid, Zyrtic and potassium